(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide

C228H164F7N41O44 — CID 161412336

IUPAC(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide
SMILESCOc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.COc1ccccc1/C=C/C(=O)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.COc1ccccc1/C=C\C(=O)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.Cc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.N#Cc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.O=C(/C=C/C=C/c1ccccc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(F)c(F)c1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(F)cc1F)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(O)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1
InChIInChI=1S/C24H18N4O4.C23H15F3N4O4.C23H15N5O4.3C23H18N4O5.C23H18N4O4.2C22H14F2N4O4.C22H16N4O5/c29-23(9-5-4-8-17-6-2-1-3-7-17)25-19-12-10-18(11-13-19)24-26-21-15-14-20(28(31)32)16-22(21)27(24)30;24-23(25,26)16-6-1-14(2-7-16)3-12-21(31)27-17-8-4-15(5-9-17)22-28-19-11-10-18(30(33)34)13-20(19)29(22)32;24-14-16-3-1-15(2-4-16)5-12-22(29)25-18-8-6-17(7-9-18)23-26-20-11-10-19(28(31)32)13-21(20)27(23)30;1-32-19-10-2-15(3-11-19)4-13-22(28)24-17-7-5-16(6-8-17)23-25-20-12-9-18(27(30)31)14-21(20)26(23)29;2*1-32-21-5-3-2-4-15(21)8-13-22(28)24-17-9-6-16(7-10-17)23-25-19-12-11-18(27(30)31)14-20(19)26(23)29;1-15-2-4-16(5-3-15)6-13-22(28)24-18-9-7-17(8-10-18)23-25-20-12-11-19(27(30)31)14-21(20)26(23)29;23-17-8-1-13(11-18(17)24)2-10-21(29)25-15-5-3-14(4-6-15)22-26-19-9-7-16(28(31)32)12-20(19)27(22)30;23-15-5-1-13(18(24)11-15)4-10-21(29)25-16-6-2-14(3-7-16)22-26-19-9-8-17(28(31)32)12-20(19)27(22)30;27-18-9-1-14(2-10-18)3-12-21(28)23-16-6-4-15(5-7-16)22-24-19-11-8-17(26(30)31)13-20(19)25(22)29/h1-16,30H,(H,25,29);1-13,32H,(H,27,31);1-13,30H,(H,25,29);3*2-14,29H,1H3,(H,24,28);2-14,29H,1H3,(H,24,28);2*1-12,30H,(H,25,29);1-13,27,29H,(H,23,28)/b8-4+,9-5+;12-3+;12-5+;13-4+;13-8+;13-8-;13-6+;10-2+;10-4+;12-3+
InChIKeyVVQFCSYOTUDAGE-ACZNXZGYSA-N
MW4315.05 g/mol
LogP47.05
Rot. Bonds54

About (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide

(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide (PubChem CID 161412336) has the molecular formula C228H164F7N41O44 and a molecular weight of 4315.05 g/mol. Its IUPAC name is (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide.

Molecular Properties

Compound Name(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide
PubChem CID161412336
Molecular FormulaC228H164F7N41O44
Molecular Weight4315.05 g/mol
Exact Mass4312.17
IUPAC Name(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide
SMILESCOc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.COc1ccccc1/C=C/C(=O)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.COc1ccccc1/C=C\C(=O)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.Cc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.N#Cc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.O=C(/C=C/C=C/c1ccccc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(F)c(F)c1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(F)cc1F)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(O)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1
InChIInChI=1S/C24H18N4O4.C23H15F3N4O4.C23H15N5O4.3C23H18N4O5.C23H18N4O4.2C22H14F2N4O4.C22H16N4O5/c29-23(9-5-4-8-17-6-2-1-3-7-17)25-19-12-10-18(11-13-19)24-26-21-15-14-20(28(31)32)16-22(21)27(24)30;24-23(25,26)16-6-1-14(2-7-16)3-12-21(31)27-17-8-4-15(5-9-17)22-28-19-11-10-18(30(33)34)13-20(19)29(22)32;24-14-16-3-1-15(2-4-16)5-12-22(29)25-18-8-6-17(7-9-18)23-26-20-11-10-19(28(31)32)13-21(20)27(23)30;1-32-19-10-2-15(3-11-19)4-13-22(28)24-17-7-5-16(6-8-17)23-25-20-12-9-18(27(30)31)14-21(20)26(23)29;2*1-32-21-5-3-2-4-15(21)8-13-22(28)24-17-9-6-16(7-10-17)23-25-19-12-11-18(27(30)31)14-20(19)26(23)29;1-15-2-4-16(5-3-15)6-13-22(28)24-18-9-7-17(8-10-18)23-25-20-12-11-19(27(30)31)14-21(20)26(23)29;23-17-8-1-13(11-18(17)24)2-10-21(29)25-15-5-3-14(4-6-15)22-26-19-9-7-16(28(31)32)12-20(19)27(22)30;23-15-5-1-13(18(24)11-15)4-10-21(29)25-16-6-2-14(3-7-16)22-26-19-9-8-17(28(31)32)12-20(19)27(22)30;27-18-9-1-14(2-10-18)3-12-21(28)23-16-6-4-15(5-7-16)22-24-19-11-8-17(26(30)31)13-20(19)25(22)29/h1-16,30H,(H,25,29);1-13,32H,(H,27,31);1-13,30H,(H,25,29);3*2-14,29H,1H3,(H,24,28);2-14,29H,1H3,(H,24,28);2*1-12,30H,(H,25,29);1-13,27,29H,(H,23,28)/b8-4+,9-5+;12-3+;12-5+;13-4+;13-8+;13-8-;13-6+;10-2+;10-4+;12-3+
InChIKeyVVQFCSYOTUDAGE-ACZNXZGYSA-N
XLogP47.05
TPSA1174.61 Ų
H-Bond Donors21
H-Bond Acceptors65
Rotatable Bonds54
Heavy Atoms320
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5004315.05
LogP ≤ 547.05
H-Bond Donors ≤ 521
H-Bond Acceptors ≤ 1065

Analyze (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-acetyl-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(E)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-3-phenylprop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide
CID 157369318
CID 157485483
CID 157485483
(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide
CID 157561683
4-cyano-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(4-fluorophenyl)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]prop-2-enamide;N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)propanamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide
CID 157948680
CID 160091356
CID 160091356
2-[4-[6-(dimethylamino)-1-hydroxybenzimidazol-2-yl]phenyl]-1-(4-fluorophenyl)ethanone;4-(dimethylamino)-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;1-[4-(dimethylamino)phenyl]-2-[4-(1-hydroxy-5-methylbenzimidazol-2-yl)phenyl]ethanone;2-[4-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]phenyl]-1-hydroxybenzimidazole-5-carbonitrile;2-[4-[2-[4-(dimethylamino)phenyl]-2-oxoethyl]phenyl]-1-hydroxybenzimidazole-5-carboxylic acid;4-fluoro-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-4-methoxybenzamide
CID 161286549
N-[4-(6-acetyl-1-hydroxybenzimidazol-2-yl)phenyl]-4-(dimethylamino)benzamide;N-[4-(5-cyano-1-hydroxybenzimidazol-2-yl)phenyl]-4-(dimethylamino)benzamide;2-[4-[[4-(dimethylamino)benzoyl]amino]phenyl]-1-hydroxybenzimidazole-5-carboxylic acid;4-(dimethylamino)-N-[4-(1-hydroxybenzimidazol-2-yl)phenyl]benzamide;N-[4-[6-(dimethylamino)-1-hydroxybenzimidazol-2-yl]phenyl]-4-fluorobenzamide;4-(dimethylamino)-N-[4-(1-hydroxy-5-methylbenzimidazol-2-yl)phenyl]benzamide;4-fluoro-N-[3-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]benzamide;4-fluoro-N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]benzamide;N-[[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]methyl]-4-methoxybenzamide
CID 161412097

Frequently Asked Questions

What is the IUPAC name of (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide?
The IUPAC name of (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide (CID 161412336) is (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide.
What is the SMILES notation for (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide?
The canonical SMILES for (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide is COc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.COc1ccccc1/C=C/C(=O)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.COc1ccccc1/C=C\C(=O)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.Cc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.N#Cc1ccc(/C=C/C(=O)Nc2ccc(-c3nc4ccc([N+](=O)[O-])cc4n3O)cc2)cc1.O=C(/C=C/C=C/c1ccccc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(F)c(F)c1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(F)cc1F)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.O=C(/C=C/c1ccc(O)cc1)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3n2O)cc1.
What is the InChIKey of (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide?
The InChIKey is VVQFCSYOTUDAGE-ACZNXZGYSA-N. The full InChI is InChI=1S/C24H18N4O4.C23H15F3N4O4.C23H15N5O4.3C23H18N4O5.C23H18N4O4.2C22H14F2N4O4.C22H16N4O5/c29-23(9-5-4-8-17-6-2-1-3-7-17)25-19-12-10-18(11-13-19)24-26-21-15-14-20(28(31)32)16-22(21)27(24)30;24-23(25,26)16-6-1-14(2-7-16)3-12-21(31)27-17-8-4-15(5-9-17)22-28-19-11-10-18(30(33)34)13-20(19)29(22)32;24-14-16-3-1-15(2-4-16)5-12-22(29)25-18-8-6-17(7-9-18)23-26-20-11-10-19(28(31)32)13-21(20)27(23)30;1-32-19-10-2-15(3-11-19)4-13-22(28)24-17-7-5-16(6-8-17)23-25-20-12-9-18(27(30)31)14-21(20)26(23)29;2*1-32-21-5-3-2-4-15(21)8-13-22(28)24-17-9-6-16(7-10-17)23-25-19-12-11-18(27(30)31)14-20(19)26(23)29;1-15-2-4-16(5-3-15)6-13-22(28)24-18-9-7-17(8-10-18)23-25-20-12-11-19(27(30)31)14-21(20)26(23)29;23-17-8-1-13(11-18(17)24)2-10-21(29)25-15-5-3-14(4-6-15)22-26-19-9-7-16(28(31)32)12-20(19)27(22)30;23-15-5-1-13(18(24)11-15)4-10-21(29)25-16-6-2-14(3-7-16)22-26-19-9-8-17(28(31)32)12-20(19)27(22)30;27-18-9-1-14(2-10-18)3-12-21(28)23-16-6-4-15(5-7-16)22-24-19-11-8-17(26(30)31)13-20(19)25(22)29/h1-16,30H,(H,25,29);1-13,32H,(H,27,31);1-13,30H,(H,25,29);3*2-14,29H,1H3,(H,24,28);2-14,29H,1H3,(H,24,28);2*1-12,30H,(H,25,29);1-13,27,29H,(H,23,28)/b8-4+,9-5+;12-3+;12-5+;13-4+;13-8+;13-8-;13-6+;10-2+;10-4+;12-3+.
What are the key properties of (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide?
(E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide has a molecular weight of 4315.05 g/mol, XLogP of 47.05, 54 rotatable bonds, 21 hydrogen bond donors, and 65 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-(4-cyanophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(2,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-3-(3,4-difluorophenyl)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-enamide;(Z)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(2-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methoxyphenyl)prop-2-enamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-(4-methylphenyl)prop-2-enamide;(2E,4E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-5-phenylpenta-2,4-dienamide;(E)-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enamide is sourced from PubChem (CID 161412336), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).